Creative Planning’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Buy
48,544
+13,976
+40% +$354K ﹤0.01% 2598
2026
Q2
$877K Buy
34,568
+7,415
+27% +$175K ﹤0.01% 2754
2026
Q1
$614K Sell
27,153
-7,310
-21% -$162K ﹤0.01% 2869
2025
Q4
$892K Buy
34,463
+8,938
+35% +$213K ﹤0.01% 2376
2025
Q3
$658K Sell
25,525
-220
-0.9% -$5.4K ﹤0.01% 2486
2025
Q2
$615K Sell
25,745
-1,364
-5% -$34.4K ﹤0.01% 2275
2025
Q1
$674K Buy
27,109
+2,463
+10% +$59K ﹤0.01% 2038
2024
Q4
$464K Buy
24,646
+8,577
+53% +$151K ﹤0.01% 2297
2024
Q3
$242K Buy
16,069
+7,795
+94% +$133K ﹤0.01% 2702
2024
Q2
$237K Buy
+8,274
New +$235K ﹤0.01% 2551
2023
Q4
– Sell
-62
Closed -$1.9K – 3002
2023
Q3
$1.9K Buy
+62
New +$2.24K ﹤0.01% 2807
2023
Q2
– Sell
-5
Closed -$205 – 2779
2023
Q1
$205 Buy
+5
New +$199 ﹤0.01% 2613
2018
Q2
– Sell
-9,050
Closed -$282K – 2147
2018
Q1
$282K Buy
+9,050
New +$322K ﹤0.01% 1378
2017
Q3
– Sell
-1,600
Closed -$76K – 3174
2017
Q2
$76K Hold
1,600
– – ﹤0.01% 2187
2017
Q1
$73K Hold
1,600
– – ﹤0.01% 2170
2016
Q4
$52K Hold
1,600
– – ﹤0.01% 2363
2016
Q3
$55K Hold
1,600
– – ﹤0.01% 2285
2016
Q2
$54K Hold
1,600
– – ﹤0.01% 2090
2016
Q1
$85K Sell
1,600
-100
-6% -$5.85K ﹤0.01% 1726
2015
Q4
$131K Buy
1,700
+600
+55% +$34K ﹤0.01% 1481
2015
Q3
$45K Buy
+1,100
New +$67.4K ﹤0.01% 2118
2015
Q2
– Sell
-1,100
Closed -$98K – 2442
2015
Q1
$98K Buy
1,100
+100
+10% +$10.1K ﹤0.01% 1581
2014
Q4
$89K Sell
1,000
-50
-5% -$4.73K ﹤0.01% 1609
2014
Q3
$102K Buy
1,050
+50
+5% +$4.86K ﹤0.01% 1461
2014
Q2
$92K Hold
1,000
– – ﹤0.01% 1489
2014
Q1
$70K Sell
1,000
-2,002
-67% -$136K ﹤0.01% 1608
2013
Q4
$173K Hold
3,002
– – ﹤0.01% 933
2013
Q3
$144K Hold
3,002
– – ﹤0.01% 912
2013
Q2
$87K Buy
+3,002
New +$86.8K ﹤0.01% 1061

Other funds holding PCRX

Creative Planning's PCRX Position: Q3 2026 in Review

Creative Planning increased its Pacira BioSciences (PCRX) stake by 40% in Q3 2026, buying an estimated $354K and bringing the position to 48,544 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

Creative Planning first reported a position in PCRX in Q2 2013 and has held it in 29 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Creative Planning held 48,544 shares of Pacira BioSciences worth $1.22M as of Q3 2026.
  • Creative Planning bought 13,976 Pacira BioSciences shares in Q3 2026, an estimated $354K.
  • Pacira BioSciences made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #2598 holding.
  • Creative Planning first reported a position in Pacira BioSciences in Q2 2013 and has held it in 29 quarters since.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.